{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:53Z","timestamp":1761894773431},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,8,9]],"date-time":"2008-08-09T00:00:00Z","timestamp":1218240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00277-008-0578-5","type":"journal-article","created":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T15:16:18Z","timestamp":1218208578000},"page":"285-286","source":"Crossref","is-referenced-by-count":8,"title":["Feasibility of a dose-adjusted fludarabine\u2013melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma"],"prefix":"10.1007","volume":"88","author":[{"given":"Andrea","family":"Tendas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Cupelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Dentamaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scaramucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Niscola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Giovannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio Pio","family":"Perrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"de Fabritiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,9]]},"reference":[{"issue":"5A","key":"578_CR1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1083-8791(00)70065-6","volume":"6","author":"LJ Johnston","year":"2000","unstructured":"Johnston LJ, Stockerl-Goldstein KE, Hu WW, Negrin RS, Hoppe RT, Blume KG et al (2000) Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory\/recurrent non-Hodgkin\u2019s lymphoma. Biol Blood Marrow Transplant 6(5A):555\u2013562 doi: 10.1016\/S1083-8791(00)70065-6","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"578_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bmt.1703198","volume":"28","author":"SM Devine","year":"2001","unstructured":"Devine SM, Sanborn R, Jessop E, Stock W, Huml M, Peace D et al (2001) Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant. Bone Marrow Transplant 28(6):557\u2013562 doi: 10.1038\/sj.bmt.1703198","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"578_CR3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1600-0609.2005.00439.x","volume":"74","author":"JT Kielstein","year":"2005","unstructured":"Kielstein JT, Stadler M, Czock D, Keller F, Hertenstein B, Radermacher J (2005) Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure. Eur J Haematol 74(6):533\u2013534 doi: 10.1111\/j.1600-0609.2005.00439.x","journal-title":"Eur J Haematol"},{"issue":"7-8","key":"578_CR4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1081\/CNV-120005903","volume":"20","author":"SM Lichtman","year":"2002","unstructured":"Lichtman SM, Etcubanas E, Budman DR, Eisenberg P, Zervos G, D\u2019Amico P et al (2002) The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study. Cancer Invest 20(7-8):904\u2013913 doi: 10.1081\/CNV-120005903","journal-title":"Cancer Invest"},{"key":"578_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000096767","volume":"153","author":"M Pineda-Roman","year":"2007","unstructured":"Pineda-Roman M, Tricot G (2007) High-dose therapy in patients with plasma cell dyscrasias and renal dysfunction. Contrib Nephrol 153:182\u2013194 doi: 10.1159\/000096767","journal-title":"Contrib Nephrol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0578-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-008-0578-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-008-0578-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:45:03Z","timestamp":1559036703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-008-0578-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1007\/s00277-008-0578-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,9]]}}}